Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 10Colorectal Neoplasms 8Stomach Neoplasms 6Pancreatic Neoplasms 5Esophageal Neoplasms 5Colonic Neoplasms 5Breast Neoplasms 5Keratosis, Actinic 4Nasopharyngeal Neoplasms 3Nasopharyngeal Carcinoma 3Carcinoma, Hepatocellular 3Recurrence 2Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Uterine Cervical Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Pathologic Complete Response 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Locally Advanced Rectal Cancer 1Keratosis 1Hyperthermia 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Appendiceal Neoplasms 1Anus Neoplasms 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Advanced Colorectal Cancer 1

Interventions

Surveys and Questionnaires 2Standard of Care 1Referral and Consultation 1Psychiatric Rehabilitation 1Methods 1Fluorouracil 1Early Intervention, Educational 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pseudomyxoma Peritonei × Fluorouracil × Clear all
NCT06839378 2026-01-06

Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei

Beijing Tsinghua Chang Gung Hospital

Phase NA Completed
36 enrolled 8 charts

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡